Viewing Study NCT04890392


Ignite Creation Date: 2025-12-24 @ 3:14 PM
Ignite Modification Date: 2026-01-05 @ 6:29 PM
Study NCT ID: NCT04890392
Status: UNKNOWN
Last Update Posted: 2021-08-12
First Post: 2021-04-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tislelizumab Combined With S-1 Plus Oxaliplatin as a Neoadjuvant Treatment in Patients With GC/GEJC
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module